Visit project | Screening period/baseline | Visits 1–2, 4–5 | Visit 3 | Visit 6 |
---|---|---|---|---|
Visiting time | –7 to 0 days | Medication 4, 8, 16, 20 weeks ±7 days | Medication 12 weeks ±7 days | Medication 24 weeks ±7 days |
Collect basic medical history | ||||
 Sign informed consent | × |  |  |  |
 Fill in general information | × |  |  |  |
 Medical history and treatment history | × |  |  |  |
 Determine inclusion and exclusion criteria | × |  |  |  |
 Vital signs | × | × | × | × |
 Physical examination | × | × | × | × |
 Comorbidity and medication records | × | × | × | × |
Monitoring and inspection | ||||
 Urine pregnancy test | × |  |  |  |
 Glycosylated hemoglobin, blood lipids | × |  | × | × |
 Fasting blood sugar and blood pressure | × | × | × | × |
Effectiveness observation | ||||
 Urinary microalbumin–creatinine ratio | × | × | × | × |
 Urinary microalbumin excretion rate | × | × | × | × |
 Serum creatinine | × | × | × | × |
 Glomerular rate filtration | × | × | × | × |
 24-h urinary microalbumin and 24-h urinary microalbumin quantification | × |  | × | × |
Physico-chemical examination | ||||
 Routine blood test and routine urine test | × |  | × | × |
 Stool routine examination | × |  | × | × |
 Vital signs | × | × | × | × |
 ECG, liver and kidney function | × |  | × | × |
 Adverse event |  | × | × | × |
Other work | ||||
 Random grouping | × |  |  |  |
 Distribute drug and patient journal cards | × | × | × |  |
 Recovery drugs, quantity statistics |  | × | × | × |
 Recycle patient’s diary card |  | × | × | × |
 End of study summary |  |  |  | × |